Drugs / Traumeel
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01912469 | Apr 2010 → Aug 2013 | — | Prof. Dr. med. Frank Christoph Mooren | Completed | No outcome recorded |
| Phase 1 | NCT01921777 | Jan 2010 → Dec 2013 | — | Prof. Dr. med. Frank Christoph Mooren | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT06192420 | Feb 2018 → Nov 2020 | — | Biologische Heilmittel Heel GmbH | Completed | No outcome recorded |
| Phase 3 | NCT01887678 | Jun 2013 → Jan 2014 | osteoarthritis, knee | Biologische Heilmittel Heel GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Traumeel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01887678 ↗ |
| Route | Other | “intra articular (IA) injection” NCT01887678 ↗ |